Deep Track Capital’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.2M | Hold |
5,380,449
| – | – | 2.41% | 14 |
|
|
2025
Q1 | $72.5M | Buy |
5,380,449
+857,708
| +19% | +$11.6M | 2.35% | 13 |
|
|
2024
Q4 | $86.7M | Buy |
4,522,741
+771,796
| +21% | +$14.8M | 3.23% | 9 |
|
|
2024
Q3 | $85.3M | Sell |
3,750,945
-172,904
| -4% | -$3.93M | 2.71% | 15 |
|
|
2024
Q2 | $51M | Buy |
3,923,849
+467,796
| +14% | +$6.09M | 1.52% | 27 |
|
|
2024
Q1 | $60.5M | Sell |
3,456,053
-175,675
| -5% | -$3.08M | 1.73% | 22 |
|
|
2023
Q4 | $79.1M | Buy |
3,631,728
+668,461
| +23% | +$14.6M | 2.64% | 10 |
|
|
2023
Q3 | $45.5M | Buy |
2,963,267
+1,683,765
| +132% | +$25.8M | 1.75% | 21 |
|
|
2023
Q2 | $30.4M | Buy |
1,279,502
+49,243
| +4% | +$1.17M | 1.41% | 21 |
|
|
2023
Q1 | $31.3M | Sell |
1,230,259
-540,895
| -31% | -$13.8M | 1.29% | 25 |
|
|
2022
Q4 | $51.7M | Sell |
1,771,154
-199,136
| -10% | -$5.82M | 2.17% | 17 |
|
|
2022
Q3 | $40.4M | Buy |
1,970,290
+800,000
| +68% | +$16.4M | 1.85% | 17 |
|
|
2022
Q2 | $13.5M | Hold |
1,170,290
| – | – | 0.89% | 33 |
|
|
2022
Q1 | $21.6M | Sell |
1,170,290
-166,400
| -12% | -$3.08M | 1.39% | 27 |
|
|
2021
Q4 | $26.4M | Buy |
+1,336,690
| New | +$26.4M | 1.87% | 20 |
|